2022 Ljubljana, Slovenia

II-46 Javier Sanchez Fernandez
Preclinical in vivo data integrated in a modeling network informs a refined clinical strategy for a CD3 T-Cell bispecific in combination with anti-PD-L1
Wednesday 15:10-16:40